Cargando…
PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429240/ http://dx.doi.org/10.1097/01.HS9.0000976016.08614.aa |
_version_ | 1785090662032474112 |
---|---|
author | Martinez, Celia Yuen, Lisa Brady, Jessica Gleeson, Mary George, Mikhaeel Stanley, Karen Paul, Fields Wrench, David |
author_facet | Martinez, Celia Yuen, Lisa Brady, Jessica Gleeson, Mary George, Mikhaeel Stanley, Karen Paul, Fields Wrench, David |
author_sort | Martinez, Celia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104292402023-08-17 PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. Martinez, Celia Yuen, Lisa Brady, Jessica Gleeson, Mary George, Mikhaeel Stanley, Karen Paul, Fields Wrench, David Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429240/ http://dx.doi.org/10.1097/01.HS9.0000976016.08614.aa Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Martinez, Celia Yuen, Lisa Brady, Jessica Gleeson, Mary George, Mikhaeel Stanley, Karen Paul, Fields Wrench, David PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. |
title | PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. |
title_full | PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. |
title_fullStr | PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. |
title_full_unstemmed | PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. |
title_short | PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. |
title_sort | pb2324: use of combination of thalidomide, cyclophosphamide and dexamethasone in patients with refractory/relapsed non-hodgkin lymphoma: a palliative chemotherapy strategy. |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429240/ http://dx.doi.org/10.1097/01.HS9.0000976016.08614.aa |
work_keys_str_mv | AT martinezcelia pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT yuenlisa pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT bradyjessica pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT gleesonmary pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT georgemikhaeel pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT stanleykaren pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT paulfields pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy AT wrenchdavid pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy |